Elevance Health, Inc. is an American multinational health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company's services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | 2025-10-28 16:55:09 | 340 | 0.6 | 0.18 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELV | 0001156039 | Elevance Health, Inc. | US0367521038 | 8MYN82XMYQH89CTMTH67 | 352145715 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | IN | 220 VIRGINIA AVENUE | INDIANAPOLIS | IN | 46204 | UNITED STATES | US | 8003311476 | 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204 | 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204 | Anthem, Inc. | Managed healthcare | 1946 | Gail Koziara Boudreaux | 104,200 | http://elevancehealth.com | 116,687,067,115 | 222,036,187 | 222,238,763 | Elevance Health, Inc. is an American multinational health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company's services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. | 2025-10-23 12:14:34 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 116,687,067,115 | 12,052,606,452 | 11.5188 | 227,351,871 | -5,316,864 | -2.2852 |
| 2023 | 104,634,460,663 | -11,057,512,330 | -9.5577 | 232,668,735 | -4,789,041 | -2.0168 |
| 2022 | 115,691,972,993 | 22,684,006,898 | 24.3893 | 237,457,776 | -3,846,593 | -1.5941 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Gail Boudreaux | Chief Executive Officer, President | 2024 | 1,600,000 | 0 | 12,600,032 | 1,142,400 | 929,555 | 20,471,976 |
| Morgan Kendrick | EVP, President | 2024 | 850,000 | 0 | 3,225,249 | 510,000 | 133,400 | 5,793,474 |
| John E. Gallina | Chief Financial Officer, EVP | 2023 | 944,231 | — | 4,312,731 | 1,314,369 | 144,881 | 8,165,416 |
| Gail K. Boudreaux | Chief Executive Officer, President | 2023 | 1,600,000 | — | 11,850,043 | 3,648,000 | 840,960 | 21,889,039 |
| Gail Boudreaux | Chief Executive Officer, President | 2023 | 1,600,000 | 0 | 11,850,043 | 3,648,000 | 840,960 | 21,889,039 |
| Fiscal Year | Employee Count |
|---|---|
| 2021 | 98,200 |
| 2020 | 83,400 |
| 2019 | 70,600 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 177,011,000,000 | 171,340,000,000 | 156,595,000,000 |
| Cost Of Revenue | 19,750,000,000 | 17,293,000,000 | 13,035,000,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 20,025,000,000 | 20,087,000,000 | 17,686,000,000 |
| Operating Expenses | — | — | — |
| Operating Income | 7,862,000,000 | 8,499,000,000 | 8,452,000,000 |
| Net Income | 5,980,000,000 | 5,987,000,000 | 6,025,000,000 |
| Earnings Per Share Basic | 25.81 | 25.38 | 25.1 |
| Earnings Per Share Diluted | 25.68 | 25.22 | 24.81 |
| Weighted Average Shares Outstanding Basic | 231,700,000 | 235,900,000 | 240,000,000 |
| Weighted Average Shares Outstanding Diluted | 232,900,000 | 237,400,000 | 242,800,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 8,288,000,000 | 6,526,000,000 | 7,387,000,000 |
| Marketable Securities Current | 25,201,000,000 | 29,614,000,000 | 25,952,000,000 |
| Accounts Receivable | — | — | — |
| Inventories | — | — | — |
| Non Trade Receivables | 6,016,000,000 | 5,405,000,000 | 4,298,000,000 |
| Other Assets Current | 4,700,000,000 | 5,795,000,000 | 5,281,000,000 |
| Total Assets Current | 58,942,000,000 | 60,029,000,000 | 55,617,000,000 |
| Marketable Securities Non Current | 1,035,000,000 | 876,000,000 | 752,000,000 |
| Property Plant And Equipment | 4,652,000,000 | 4,359,000,000 | 4,316,000,000 |
| Other Assets Non Current | 2,140,000,000 | 1,967,000,000 | 1,704,000,000 |
| Total Assets Non Current | 57,947,000,000 | 48,899,000,000 | 47,155,000,000 |
| Total Assets | 116,889,000,000 | 108,928,000,000 | 102,772,000,000 |
| Accounts Payable | 6,927,000,000 | 6,910,000,000 | 5,607,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 365,000,000 | 225,000,000 | 265,000,000 |
| Other Liabilities Current | 10,029,000,000 | 9,894,000,000 | 9,683,000,000 |
| Total Liabilities Current | 40,581,000,000 | 41,791,000,000 | 39,696,000,000 |
| Long Term Debt | 30,867,000,000 | 24,895,000,000 | 23,849,000,000 |
| Other Liabilities Non Current | 3,326,000,000 | 1,738,000,000 | 1,562,000,000 |
| Total Liabilities Non Current | 34,882,000,000 | 27,732,000,000 | 26,682,000,000 |
| Total Liabilities | 75,463,000,000 | 69,523,000,000 | 66,378,000,000 |
| Common Stock | 2,000,000 | 2,000,000 | 2,000,000 |
| Retained Earnings | 33,549,000,000 | 31,749,000,000 | 29,724,000,000 |
| Accumulated Other Comprehensive Income | -1,147,000,000 | -1,313,000,000 | -2,503,000,000 |
| Total Shareholders Equity | 41,315,000,000 | 39,306,000,000 | 36,307,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 1,393,000,000 | 1,745,000,000 | 1,675,000,000 |
| Share Based Compensation Expense | 191,000,000 | 289,000,000 | 264,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 683,000,000 | 1,762,000,000 | 2,510,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -824,000,000 | 675,000,000 | -120,000,000 |
| Change In Accounts Payable | — | — | — |
| Change In Other Liabilities | -39,000,000 | -7,000,000 | 66,000,000 |
| Cash From Operating Activities | 5,808,000,000 | 8,061,000,000 | 8,399,000,000 |
| Purchases Of Marketable Securities | 17,986,000,000 | 16,236,000,000 | 24,946,000,000 |
| Sales Of Marketable Securities | 2,025,000,000 | 2,940,000,000 | 10,620,000,000 |
| Acquisition Of Property Plant And Equipment | 1,256,000,000 | 1,296,000,000 | 1,152,000,000 |
| Acquisition Of Business | 4,809,000,000 | 1,552,000,000 | 649,000,000 |
| Other Investing Activities | 124,000,000 | 102,000,000 | 120,000,000 |
| Cash From Investing Activities | -5,167,000,000 | -5,572,000,000 | -4,560,000,000 |
| Tax Withholding For Share Based Compensation | 109,000,000 | 99,000,000 | 93,000,000 |
| Payments Of Dividends | 1,518,000,000 | 1,404,000,000 | 1,234,000,000 |
| Issuance Of Common Stock | 221,000,000 | 65,000,000 | 62,000,000 |
| Repurchase Of Common Stock | 2,900,000,000 | 2,676,000,000 | 2,316,000,000 |
| Issuance Of Long Term Debt | 7,710,000,000 | 2,574,000,000 | 3,071,000,000 |
| Repayment Of Long Term Debt | 1,650,000,000 | 1,909,000,000 | 1,899,000,000 |
| Other Financing Activities | 2,000,000 | 7,000,000 | 41,000,000 |
| Cash From Financing Activities | 1,193,000,000 | -3,349,000,000 | -1,318,000,000 |
| Change In Cash | 1,828,000,000 | -861,000,000 | 2,507,000,000 |
| Cash At End Of Period | 8,288,000,000 | 6,526,000,000 | 7,387,000,000 |
| Income Taxes Paid | 1,303,000,000 | 1,936,000,000 | 1,594,000,000 |
| Interest Paid | 1,239,000,000 | 1,032,000,000 | 878,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 25.81 | 25.38 | 25.1 |
| Price To Earnings Ratio | 14.2929 | 18.58 | 20.4371 |
| Earnings Growth Rate | 1.6942 | 1.1155 | 0.2396 |
| Price Earnings To Growth Ratio | 8.4361 | 16.6556 | 85.2906 |
| Book Value Per Share | 178.7915 | 167.0411 | 151.6417 |
| Price To Book Ratio | 2.0633 | 2.823 | 3.3828 |
| Ebitda | 9,861,000,000 | 10,698,000,000 | 10,145,000,000 |
| Enterprise Value | 108,418,130,000 | 129,835,004,000 | 139,839,800,000 |
| Dividend Yield | 0.0178 | 0.0126 | 0.01 |
| Dividend Payout Ratio | 0.2538 | 0.2345 | 0.2048 |
| Debt To Equity Ratio | 0.7559 | 0.6391 | 0.6642 |
| Capital Expenditures | 1,686,000,000 | 1,788,000,000 | 2,072,000,000 |
| Free Cash Flow | 4,122,000,000 | 6,273,000,000 | 6,327,000,000 |
| Return On Equity | 0.1447 | 0.1523 | 0.1659 |
| One Year Beta | 0.3695 | 0.5238 | 0.5565 |
| Three Year Beta | 0.5106 | 0.5698 | 0.9685 |
| Five Year Beta | 0.8887 | 0.9254 | 0.9448 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Kaye Mark | EVP & CFO | 2025-10-02 | 2,895 | D | 16,082 |
| Wessling Erin M | EVP & Chief Legal Officer | 2025-09-03 | 152 | D | 5,020 |
| Craig Ryan R | EVP & Chief HR Officer | 2025-09-02 | 970 | A | 5,353 |
| Craig Ryan R | EVP & Chief HR Officer | 2025-09-02 | 3,690 | A | 3,690 |
| Wessling Erin M | EVP & Chief Legal Officer | 2025-09-02 | 931 | A | 5,172 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Markwayne Mullin | Senator | 2023-11-01 | Purchase | 2023-10-03 | Joint | $1,001 - $15,000 |
| Markwayne Mullin | Senator | 2023-10-12 | Purchase | 2023-09-13 | Joint | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Valerie Hoyle | 2025-09-12 | OR04 | Purchase | 2024-10-29 | Spouse | $1,001 - $15,000 |
| Valerie Hoyle | 2025-09-12 | OR04 | Sale | 2025-01-13 | Spouse | $1,001 - $15,000 |
| Lisa McClain | 2025-09-12 | MI09 | Sale | 2025-08-13 | Spouse | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-09-12 | CA31 | Purchase | 2025-08-05 | — | $1,001 - $15,000 |
| Lisa McClain | 2025-08-13 | MI09 | Purchase | 2025-07-10 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| QRG CAPITAL MANAGEMENT, INC. | 2025-09-30 | 3,294,902 | 10,197 | 323.1246 |
| EVERGREEN CAPITAL MANAGEMENT LLC | 2025-09-30 | 313,428 | 970 | 323.1216 |
| LEAVELL INVESTMENT MANAGEMENT, INC. | 2025-09-30 | 997,225 | 3,086 | 323.1448 |
| Confluence Wealth Services, Inc. | 2025-09-30 | 428,134 | 1,325 | 323.12 |
| Arlington Trust Co LLC | 2025-09-30 | 126,017 | 390 | 323.1205 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| FORUM FUNDS | 2025-09-30 | Institutional Shares | AUXIX | 12,161 | 3,929,462.32 | 1.2576 |
| FORUM FUNDS | 2025-09-30 | Investor Shares | AUXFX | 12,161 | 3,929,462.32 | 1.2576 |
| FORUM FUNDS | 2025-09-30 | A Shares | AUXAX | 12,161 | 3,929,462.32 | 1.2576 |
| Meeder Funds | 2025-09-30 | Adviser Class | SRUAX | 988 | 319,242.56 | 0.1304 |
| Meeder Funds | 2025-09-30 | Institutional Class | SRUIX | 988 | 319,242.56 | 0.1304 |